Brokers usually take bids until: Zerodha 4:45 PM, Groww 4:50 PM, Angel One and Upstox 5:00 PM (HNI 4:00 PM). Check the exact time with your broker or bank.
Total Issue Size
Fresh Issue + Offer For Sale
Fresh Issue (FI)
Proceeds go to the company
Offer For Sale (OFS)
Proceeds go to the existing investors
Early redemption of non-convertible debentures
Early redemption of non-convertible debentures issued to CDC Emerging Markets Limited.
Capital expenditure for new hospitals
Funding capital expenditure toward setting up new hospitals.
General corporate purposes
Balance of the fresh issue proceeds for general corporate purposes.
No lots distribution added yet.
(₹ in Crore)
Tap a bar to highlight a metric across periods and show its values.
No peer comparisons added yet.
Rainbow Children's Medicare Limited operates a multi-specialty pediatric, obstetrics and gynecology hospital chain in India. The company opened its first pediatric specialty hospital in Hyderabad in 1999, and by the time of its IPO ran 14 hospitals and three clinics across six cities with a combined bed capacity of around 1,500 beds. Its services span newborn and pediatric intensive care, multi-specialty pediatric care, pediatric quaternary care, obstetrics and gynecology, and multidisciplinary fetal care. The company follows a doctor engagement model under which most of its core specialists work exclusively at its hospitals on a full time basis, supporting round the clock availability for children's emergency, neonatal and pediatric intensive care services. It has counted UK based development finance institution CDC Group among its shareholders. At the time of listing, independent industry research cited Rainbow as having the highest number of hospital beds in India's maternity and pediatric healthcare delivery segment, reflecting its position as a leading specialist operator in a niche, high growth segment of the broader hospital industry.
Rainbow Children's Medicare allotted shares to 36 anchor investors ahead of the issue opening, with participation from institutional names including the Government of Singapore, Monetary Authority of Singapore, Goldman Sachs, HSBC, Axis Mutual Fund, HDFC Life Insurance, DSP Mutual Fund, Motilal Oswal Mutual Fund, UTI Mutual Fund and Max Life Insurance.
Source: RHP • Analysis provided for informational purposes
Last Updated: 19 July 2026, 5:30 AM
Leading pediatric hospital network
The company operates one of India's largest specialist networks dedicated to pediatric and maternity care, with a long operating history dating back to 1999.
Doctor retention model
Core specialists work exclusively and full time at the company's hospitals, supporting consistent round the clock clinical availability.
Established multi-city presence
The hospital network spans multiple Indian cities, giving the company scale and brand recognition in a niche specialty segment.
Institutional and development-finance backing
The company has counted global institutional investors among its shareholders, reflecting external validation of its business model.
Concentration in a single specialty segment
The company's revenue is concentrated in pediatric and maternity care, making it more exposed to shifts in that specific segment than a general hospital operator.
Geographic concentration
A large share of revenue comes from a limited number of cities, so the company is more exposed to local demand or regulatory shifts than a nationally diversified peer.
High valuation at listing
The issue was priced at a rich earnings multiple relative to reported profits, leaving limited valuation cushion if growth slows.
Rainbow Children's Medicare Limited
8-2-120/103/1, Survey No. 403, Road No. 2, Banjara Hills, Hyderabad, Telangana 500034, India
View on Maps →No financial information whatsoever published anywhere, within this website, should be considered as an advice to buy or sell securities or invest in IPOs, or as a guide to doing so in any way whatsoever. All matter published here is purely for educational and information purposes only and under no circumstances should be used for making investment decisions.
We are not a SEBI Registered analyst. Readers must consult a qualified financial advisor prior to making any actual investment decisions, based on information published on this website. The information on this website is based on information available as on date coupled with market perceptions.
You agree with the terms and conditions to use this website.
Grey-market disclaimer. GMP shown here is grey-market news only. We do not trade or deal in the grey market or subject-to rates, nor do we recommend trading in the grey market.
Not investment advice. IPO Nex is an information tool, not investment advice. We do not recommend buying or selling any securities. Always do your own research before applying to any IPO.
IPO Nex does not guarantee any listing gain or return. IPO investments are subject to market risks.
All times are IST.
© 2026 IPO Nex by Niota. All rights reserved.